{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:31:40Z","timestamp":1761363100145,"version":"build-2065373602"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011302","name":"Children's Hospital Foundation","doi-asserted-by":"publisher","award":["RPC00095"],"award-info":[{"award-number":["RPC00095"]}],"id":[{"id":"10.13039\/100011302","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["IH190100021"],"award-info":[{"award-number":["IH190100021"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jcv.2023.105556","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T23:54:15Z","timestamp":1691106855000},"page":"105556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Application of the ViroKey\u00ae SQ FLEX assay for detection of cytomegalovirus antiviral resistance"],"prefix":"10.1016","volume":"167","author":[{"given":"Jocelyn","family":"Hume","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kym","family":"Lowry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Whiley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam D.","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Bletchly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma L.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jcv.2023.105556_bib0001","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1128\/CVI.00203-06","article-title":"National serosurvey of cytomegalovirus in Australia","volume":"13","author":"Seale","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"issue":"7","key":"10.1016\/j.jcv.2023.105556_bib0002","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1073\/pnas.91.7.2384","article-title":"Working parents: the impact of day care and breast-feeding on cytomegalovirus infections in offspring","volume":"91","author":"Stagno","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.jcv.2023.105556_bib0003","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/tid.12311","article-title":"The impact of drug-resistant cytomegalovirus in pediatric allogeneic hematopoietic cell transplant recipients: a prospective monitoring of UL97 and UL54 gene mutations","volume":"16","author":"Choi","year":"2014","journal-title":"Transpl. Infect. Dis."},{"issue":"7","key":"10.1016\/j.jcv.2023.105556_bib0004","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/sj.bmt.1703513","article-title":"Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction","volume":"29","author":"Yakushiji","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jcv.2023.105556_bib0005","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1399-3062.2010.00504.x","article-title":"Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy","volume":"12","author":"George","year":"2010","journal-title":"Transpl. Infect. Dis."},{"issue":"11","key":"10.1016\/j.jcv.2023.105556_bib0006","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/infdis\/jix192","article-title":"Identifying cytomegalovirus complications using the quantiferon-CMV assay after allogeneic hematopoietic stem cell transplantation","volume":"215","author":"Yong","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.jcv.2023.105556_bib0007","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1111\/ajt.15515","article-title":"Cytomegalovirus (CMV) infection and risk of mortality in allogeneic hematopoietic stem cell transplantation (Allo-HSCT): a systematic review, meta-analysis, and meta-regression analysis","volume":"19","author":"Gimenez","year":"2019","journal-title":"Am. J. Transplant."},{"issue":"7","key":"10.1016\/j.jcv.2023.105556_bib0008","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1182\/blood-2013-02-487074","article-title":"CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia","volume":"122","author":"Green","year":"2013","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.jcv.2023.105556_bib0009","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/blood-2015-11-679639","article-title":"Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis","volume":"127","author":"Teira","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jcv.2023.105556_bib0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/sj.bmt.1705699","article-title":"Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies","volume":"40","author":"Ozdemir","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jcv.2023.105556_bib0011","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jcyt.2021.10.002","article-title":"Time to initiation of pre-emptive therapy for cytomegalovirus impacts overall survival in pediatric hematopoietic stem cell transplant recipients","volume":"24","author":"Camacho-Bydume","year":"2022","journal-title":"Cytotherapy"},{"issue":"7","key":"10.1016\/j.jcv.2023.105556_bib0012","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.bbmt.2016.04.004","article-title":"Cytomegalovirus infection in pediatric hematopoietic stem cell transplantation: risk factors for primary infection and cases of recurrent and late infection at a single center","volume":"22","author":"Rowe","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"8","key":"10.1016\/j.jcv.2023.105556_bib0013","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1016\/S1473-3099(19)30107-0","article-title":"Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)","volume":"19","author":"Ljungman","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jcv.2023.105556_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104711","article-title":"Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistance","volume":"176","author":"Chou","year":"2020","journal-title":"Antiviral Res."},{"issue":"4","key":"10.1016\/j.jcv.2023.105556_bib0015","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/infdis\/jit475","article-title":"High rate of cytomegalovirus drug resistance among patients receiving preemptive antiviral treatment after haploidentical stem cell transplantation","volume":"209","author":"Shmueli","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"17","key":"10.1016\/j.jcv.2023.105556_bib0016","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.3390\/jcm11175187","article-title":"The impact of high CMV viral load and refractory CMV infection on pediatric HSCT recipients with underlying non-malignant disorder","volume":"11","author":"Szmit","year":"2022","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.jcv.2023.105556_bib0017","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/jmv.20150","article-title":"Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations","volume":"74","author":"Scott","year":"2004","journal-title":"J. Med. Virol."},{"issue":"3","key":"10.1016\/j.jcv.2023.105556_bib0019","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/S2352-3026(15)00289-6","article-title":"Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study","volume":"3","author":"Green","year":"2016","journal-title":"Lancet Haematol."},{"issue":"1","key":"10.1016\/j.jcv.2023.105556_bib0020","doi-asserted-by":"crossref","first-page":"24067","DOI":"10.1038\/srep24067","article-title":"Comparison of DNA quantification methods for next generation sequencing","volume":"6","author":"Robin","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jcv.2023.105556_bib0021","unstructured":"Inc. TFS. Torrent SuiteTM Software 5.16 user guide; 2021."},{"key":"10.1016\/j.jcv.2023.105556_bib0022","unstructured":"Inc. TFS. Ion PGMTM template OT2 400 kit; 2014."},{"issue":"5","key":"10.1016\/j.jcv.2023.105556_bib0023","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052727","article-title":"Analytical assessment of the Vela Diagnostics NGS assay for HIV genotyping and resistance testing: the Apulian Experience","volume":"23","author":"Bonifacio","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.jcv.2023.105556_bib0024","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jmoldx.2019.06.003","article-title":"Prospective evaluation of the Vela Diagnostics next-generation sequencing platform for HIV-1 genotypic resistance testing","volume":"21","author":"Weber","year":"2019","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.jcv.2023.105556_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2019.104207","article-title":"Routine drug resistance testing in HIV-1 proviral DNA, using an automated next- generation sequencing assay","volume":"121","author":"Alidjinou","year":"2019","journal-title":"J. Clin. Virol."},{"issue":"5","key":"10.1016\/j.jcv.2023.105556_bib0026","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/jac\/dky003","article-title":"HIV-1 genotypic resistance testing using the Vela automated next-generation sequencing platform","volume":"73","author":"Raymond","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jcv.2023.105556_bib0027","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jviromet.2017.10.005","article-title":"A novel next generation sequencing assay as an alternative to currently available methods for hepatitis C virus genotyping","volume":"251","author":"Dirani","year":"2018","journal-title":"J. Virol. Methods"},{"issue":"12","key":"10.1016\/j.jcv.2023.105556_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209561","article-title":"First evaluation of the next-generation sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium","volume":"13","author":"Dessilly","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcv.2023.105556_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104376","article-title":"Evaluation of Vela Diagnostics HIV-1 genotyping assay on an automated next generation sequencing platform","volume":"127","author":"May","year":"2020","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2023.105556_bib0030","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jcv.2019.09.011","article-title":"Prevalence of baseline HCV NS5A resistance associated substitutions in genotype 1a, 1b and 3 infection in Australia","volume":"120","author":"Papaluca","year":"2019","journal-title":"J. Clin. Virol."},{"issue":"5","key":"10.1016\/j.jcv.2023.105556_bib0031","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1086\/655397","article-title":"Minority variants of drug-resistant HIV","volume":"202","author":"Gianella","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.jcv.2023.105556_bib0032","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1371\/journal.pmed.0050158","article-title":"Minority HIV-1 drug resistance mutations are present in antiretroviral treatment\u2013Na\u00efve populations and associate with reduced treatment efficacy","volume":"5","author":"Johnson","year":"2008","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.jcv.2023.105556_bib0033","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/AAC.01177-08","article-title":"Diverse cytomegalovirus UL27 mutations adapt to loss of viral UL97 kinase activity under maribavir","volume":"53","author":"Chou","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.jcv.2023.105556_bib0034","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.antiviral.2011.08.019","article-title":"Resistance to maribavir is associated with the exclusion of pUL27 from nucleoli during human cytomegalovirus infection","volume":"92","author":"Hakki","year":"2011","journal-title":"Antiviral Res."},{"issue":"6","key":"10.1016\/j.jcv.2023.105556_bib0035","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1128\/JVI.72.6.4721-4728.1998","article-title":"Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56","volume":"72","author":"Krosky","year":"1998","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.jcv.2023.105556_bib0036","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01325-17","article-title":"Comparison of cytomegalovirus terminase gene mutations selected after exposure to three distinct inhibitor compounds","volume":"61","author":"Chou","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.jcv.2023.105556_bib0037","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00922-18","article-title":"New locus of drug resistance in the human cytomegalovirus UL56 gene revealed by in vitro exposure to letermovir and ganciclovir","volume":"62","author":"Chou","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.jcv.2023.105556_bib0038","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1128\/AAC.00633-06","article-title":"Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates","volume":"51","author":"Scott","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.jcv.2023.105556_bib0039","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1128\/AAC.00214-16","article-title":"Novel cytomegalovirus UL54 DNA polymerase gene mutations selected in vitro that confer brincidofovir resistance","volume":"60","author":"Chou","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jcv.2023.105556_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105181","article-title":"Opposite effects of cytomegalovirus UL54 exonuclease domain mutations on acyclovir and cidofovir susceptibility","volume":"195","author":"Chou","year":"2021","journal-title":"Antiviral Res."},{"issue":"2","key":"10.1016\/j.jcv.2023.105556_bib0041","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jcv.2006.07.010","article-title":"Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet","volume":"37","author":"Drew","year":"2006","journal-title":"J. Clin. Virol."},{"issue":"1","key":"10.1016\/j.jcv.2023.105556_bib0042","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1128\/JVI.01787-07","article-title":"Accelerated evolution of maribavir resistance in a cytomegalovirus exonuclease domain II mutant","volume":"82","author":"Chou","year":"2008","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.jcv.2023.105556_bib0043","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2042-4280-1-4","article-title":"The effects of maribavir on the autophosphorylation of ganciclovir resistant mutants of the cytomegalovirus UL97 protein","volume":"1","author":"Shannon-Lowe","year":"2010","journal-title":"Herpesviridae"},{"key":"10.1016\/j.jcv.2023.105556_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104616","article-title":"Novel UL97 drug resistance mutations identified at baseline in a clinical trial of maribavir for resistant or refractory cytomegalovirus infection","volume":"172","author":"Chou","year":"2019","journal-title":"Antiviral Res."},{"issue":"4","key":"10.1016\/j.jcv.2023.105556_bib0045","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/infdis\/jiaa462","article-title":"Drug resistance mutations and associated phenotypes detected in clinical trials of maribavir for treatment of cytomegalovirus infection","volume":"226","author":"Chou","year":"2022","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.jcv.2023.105556_bib0046","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1086\/653122","article-title":"Virologic characterization of multidrug-resistant cytomegalovirus infection in 2 transplant recipients treated with maribavir","volume":"202","author":"Strasfeld","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2023.105556_bib0047","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/1471-2334-13-330","article-title":"Fast selection of maribavir resistant cytomegalovirus in a bone marrow transplant recipient","volume":"13","author":"Schubert","year":"2013","journal-title":"BMC Infect. Dis."},{"issue":"7","key":"10.1016\/j.jcv.2023.105556_bib0048","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1128\/JCM.00391-17","article-title":"Differentiated levels of ganciclovir resistance conferred by mutations at codons 591 to 603 of the cytomegalovirus UL97 kinase gene","volume":"55","author":"Chou","year":"2017","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.jcv.2023.105556_bib0049","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jcv.2012.01.020","article-title":"Multiple ganciclovir-resistant strains in a newborn with symptomatic congenital human cytomegalovirus infection","volume":"54","author":"Campanini","year":"2012","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2023.105556_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2016.04.002","article-title":"Identification of resistance-associated HCMV UL97- and UL54-mutations and a UL97-polymporphism with impact on phenotypic drug-resistance","volume":"131","author":"Fischer","year":"2016","journal-title":"Antiviral Res."},{"issue":"2","key":"10.1016\/j.jcv.2023.105556_bib0051","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.antiviral.2012.05.013","article-title":"Effects on maribavir susceptibility of cytomegalovirus UL97 kinase ATP binding region mutations detected after drug exposure in vitro and in vivo","volume":"95","author":"Chou","year":"2012","journal-title":"Antiviral Res."},{"issue":"12","key":"10.1016\/j.jcv.2023.105556_bib0052","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1111\/ajt.15135","article-title":"Emergence of letermovir resistance in a lung transplant recipient with ganciclovir-resistant cytomegalovirus infection","volume":"18","author":"Cherrier","year":"2018","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2023.105556_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105139","article-title":"Ganciclovir and maribavir susceptibility phenotypes of cytomegalovirus UL97 ATP binding region mutations detected by expanded genotypic testing","volume":"193","author":"Chou","year":"2021","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jcv.2023.105556_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105422","article-title":"Relative frequency of cytomegalovirus UL56 gene mutations detected in genotypic letermovir resistance testing","volume":"207","author":"Chou","year":"2022","journal-title":"Antiviral Res."},{"issue":"1","key":"10.1016\/j.jcv.2023.105556_bib0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jcv.2008.04.005","article-title":"Contrasting drug resistance phenotypes resulting from cytomegalovirus DNA polymerase mutations at the same exonuclease locus","volume":"43","author":"Chou","year":"2008","journal-title":"J. Clin. Virol."},{"issue":"8","key":"10.1016\/j.jcv.2023.105556_bib0056","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/infdis\/jit654","article-title":"Phenotypic evaluation of previously uncharacterized cytomegalovirus DNA polymerase sequence variants detected in a valganciclovir treatment trial","volume":"209","author":"Chou","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.jcv.2023.105556_bib0057","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1128\/AAC.00511-13","article-title":"Cytomegalovirus UL97 kinase catalytic domain mutations that confer multidrug resistance","volume":"57","author":"Chou","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.jcv.2023.105556_bib0058","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1128\/AAC.01623-15","article-title":"Rapid in vitro evolution of human cytomegalovirus UL56 mutations that confer letermovir resistance","volume":"59","author":"Chou","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.jcv.2023.105556_bib0059","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1128\/AAC.05559-11","article-title":"Cyclopropavir susceptibility of cytomegalovirus DNA polymerase mutants selected after antiviral drug exposure","volume":"56","author":"Chou","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.jcv.2023.105556_bib0060","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/infdis\/jiz577","article-title":"Letermovir resistance analysis in a clinical trial of cytomegalovirus prophylaxis for hematopoietic stem cell transplant recipients","volume":"221","author":"Douglas","year":"2020","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.jcv.2023.105556_bib0061","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1128\/AAC.00334-11","article-title":"Recombinant phenotyping of cytomegalovirus UL54 mutations that emerged during cell passages in the presence of either ganciclovir or foscarnet","volume":"55","author":"Gilbert","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.jcv.2023.105556_bib0062","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1128\/AAC.49.12.4860-4866.2005","article-title":"New reporter cell line to evaluate the sequential emergence of multiple human cytomegalovirus mutations during in vitro drug exposure","volume":"49","author":"Gilbert","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.jcv.2023.105556_bib0063","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.antiviral.2013.02.002","article-title":"Novel DNA polymerase mutations conferring cytomegalovirus resistance: input of BAC-recombinant phenotyping and 3D model","volume":"98","author":"Hantz","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jcv.2023.105556_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104549","article-title":"In-depth genomic analyses identified novel letermovir resistance-associated substitutions in the cytomegalovirus UL56 and UL89 gene products","volume":"169","author":"Komatsu","year":"2019","journal-title":"Antiviral Res."},{"issue":"1","key":"10.1016\/j.jcv.2023.105556_bib0065","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1128\/AAC.01726-13","article-title":"Human cytomegalovirus UL97 kinase is involved in the mechanism of action of methylenecyclopropane analogs with 6-ether and -thioether substitutions","volume":"58","author":"Komazin-Meredith","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"17","key":"10.1016\/j.jcv.2023.105556_bib0066","doi-asserted-by":"crossref","first-page":"9084","DOI":"10.1128\/JVI.78.17.9084-9092.2004","article-title":"Specific residues in the connector loop of the human cytomegalovirus DNA polymerase accessory protein UL44 are crucial for interaction with the UL54 catalytic subunit","volume":"78","author":"Loregian","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2023.105556_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105361","article-title":"First clinical description of letermovir resistance mutation in cytomegalovirus UL51 gene and potential impact on the terminase complex structure","volume":"204","author":"Muller","year":"2022","journal-title":"Antiviral Res."},{"issue":"8","key":"10.1016\/j.jcv.2023.105556_bib0068","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1128\/JVI.03360-14","article-title":"Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility","volume":"89","author":"Piret","year":"2015","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.jcv.2023.105556_bib0069","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1093\/infdis\/jiz298","article-title":"Compartmentalization of a multidrug-resistant cytomegalovirus UL54 mutant in a stem cell transplant recipient with encephalitis","volume":"220","author":"Piret","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2023.105556_bib0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.antiviral.2016.12.003","article-title":"Foscarnet resistance mutations mapping to atypical domains of the cytomegalovirus DNA polymerase gene","volume":"138","author":"Chou","year":"2017","journal-title":"Antiviral Res."},{"issue":"1","key":"10.1016\/j.jcv.2023.105556_bib0071","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/375743","article-title":"Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus","volume":"188","author":"Chou","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.jcv.2023.105556_bib0072","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/cid\/ciy549","article-title":"Autologous adoptive T-cell therapy for recurrent or drug-resistant cytomegalovirus complications in solid organ transplant recipients: a single-arm open-label phase I clinical trial","volume":"68","author":"Smith","year":"2019","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.jcv.2023.105556_bib0073","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1093\/jac\/dkz196","article-title":"Antiviral-resistant cytomegalovirus infections in solid organ transplantation in the Netherlands","volume":"74","author":"Van Leer Buter","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.jcv.2023.105556_bib0074","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/AAC.01259-10","article-title":"Cytomegalovirus UL97 mutations affecting cyclopropavir and ganciclovir susceptibility","volume":"55","author":"Chou","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jcv.2023.105556_bib0075","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.771978","article-title":"Analysis of novel drug-resistant human cytomegalovirus DNA polymerase mutations reveals the role of a DNA-binding loop in phosphonoformic acid resistance","volume":"13","author":"Park","year":"2022","journal-title":"Front. Microbiol."},{"issue":"9","key":"10.1016\/j.jcv.2023.105556_bib0076","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/infdis\/jiac349","article-title":"Genotypic and phenotypic study of antiviral resistance mutations in refractory cytomegalovirus infection","volume":"226","author":"Santos Bravo","year":"2022","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.jcv.2023.105556_bib0077","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/infdis\/jiab029","article-title":"Phenotype and genotype study of novel C480F maribavir-ganciclovir cross-resistance mutation detected in hematopoietic stem cell and solid organ transplant recipients","volume":"224","author":"Santos Bravo","year":"2021","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.jcv.2023.105556_bib0078","first-page":"518","article-title":"Cytomegalovirus UL97 ganciclovir resistance mutations in kidney transplant recipients","volume":"123","author":"Tasoujlu","year":"2022","journal-title":"Bratisl. Lek Listy"},{"issue":"3","key":"10.1016\/j.jcv.2023.105556_bib0079","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1128\/JVI.80.3.1440-1450.2006","article-title":"Role of helix P of the human cytomegalovirus DNA polymerase in resistance and hypersusceptibility to the antiviral drug foscarnet","volume":"80","author":"Tchesnokov","year":"2006","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.jcv.2023.105556_bib0080","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00390-21","article-title":"Impact of amino acid substitutions in region II and helix K of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on resistance to foscarnet","volume":"65","author":"Zarrouk","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.jcv.2023.105556_bib0081","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1086\/338362","article-title":"Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir","volume":"185","author":"Chou","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.jcv.2023.105556_bib0082","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/jac\/dkn521","article-title":"Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus","volume":"63","author":"Allice","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.jcv.2023.105556_bib0083","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jcv.2011.12.019","article-title":"Incidence of cytomegalovirus UL97 and UL54 amino acid substitutions detected after 100 or 200 days of valganciclovir prophylaxis","volume":"53","author":"Boivin","year":"2012","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2023.105556_bib0084","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.antiviral.2016.10.016","article-title":"Genotypic resistance of cytomegalovirus to antivirals in hematopoietic stem cell transplant recipients from Portugal: a retrospective study","volume":"138","author":"Campos","year":"2017","journal-title":"Antiviral Res."},{"issue":"1","key":"10.1016\/j.jcv.2023.105556_bib0085","first-page":"51","article-title":"Ganciclovir resistance mutations in UL97 and UL54 genes of human cytomegalovirus isolates resistant to ganciclovir","volume":"48","author":"Foulongne","year":"2004","journal-title":"Acta Virol."},{"issue":"11","key":"10.1016\/j.jcv.2023.105556_bib0086","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.medcli.2019.07.027","article-title":"Study of cytomegalovirus resistance in allogeneic hematopoietic cell transplant recipients","volume":"154","author":"Guiu","year":"2020","journal-title":"Med. Clin. (Barc)"},{"issue":"2","key":"10.1016\/j.jcv.2023.105556_bib0087","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jcv.2007.07.003","article-title":"Emergence and persistence of multiple antiviral-resistant CMV strains in a highly immunocompromised child","volume":"40","author":"Iwasenko","year":"2007","journal-title":"J. Clin. Virol."},{"issue":"5","key":"10.1016\/j.jcv.2023.105556_bib0088","doi-asserted-by":"crossref","first-page":"e31733","DOI":"10.5812\/jjm.31733","article-title":"Assessment of the human cytomegalovirus UL97 gene for identification of resistance to ganciclovir in Iranian immunosuppressed patients","volume":"9","author":"Keyvani","year":"2016","journal-title":"Jundishapur J. Microbiol."},{"issue":"10","key":"10.1016\/j.jcv.2023.105556_bib0089","doi-asserted-by":"crossref","first-page":"ofab462","DOI":"10.1093\/ofid\/ofab462","article-title":"Development and dynamics of cytomegalovirus UL97 ganciclovir resistance mutations in transplant recipients detected by next-generation sequencing","volume":"8","author":"Lodding","year":"2021","journal-title":"Open Forum Infect. Dis."},{"issue":"6","key":"10.1016\/j.jcv.2023.105556_bib0090","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1399-3062.2012.00760.x","article-title":"Cytomegalovirus infection and ganciclovir resistance caused by UL97 mutations in pediatric transplant recipients","volume":"14","author":"Kim","year":"2012","journal-title":"Transpl. Infect. Dis."},{"issue":"13\u201314","key":"10.1016\/j.jcv.2023.105556_bib0091","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.intimp.2006.07.022","article-title":"The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients","volume":"6","author":"Nogueira","year":"2006","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jcv.2023.105556_bib0092","doi-asserted-by":"crossref","unstructured":"Suarez N.M., Blyth E., Li K., Ganzenmueller T., Camiolo S., Avdic S., et\u00a0al. Whole-genome approach to assessing human cytomegalovirus dynamics in transplant patients undergoing antiviral therapy. Front. Cell. Infect. Microbiol. 2020;10:267.","DOI":"10.3389\/fcimb.2020.00267"},{"issue":"2","key":"10.1016\/j.jcv.2023.105556_bib0093","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jcv.2014.07.008","article-title":"Detecting human cytomegalovirus drug resistant mutations and monitoring the emergence of resistant strains using real-time PCR","volume":"61","author":"Volfova","year":"2014","journal-title":"J. Clin. Virol."},{"issue":"5","key":"10.1016\/j.jcv.2023.105556_bib0094","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jmii.2021.01.007","article-title":"Molecular epidemiology of cytomegalovirus UL97 and UL54 variants in Taiwan","volume":"54","author":"Yang","year":"2021","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"2","key":"10.1016\/j.jcv.2023.105556_bib0095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1399-3062.2010.00584.x","article-title":"Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients","volume":"13","author":"Iwasenko","year":"2011","journal-title":"Transpl. Infect. Dis."},{"issue":"11","key":"10.1016\/j.jcv.2023.105556_bib0096","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/infdis\/jix157","article-title":"Characterization of human cytomegalovirus genome diversity in immunocompromised hosts by whole-genome sequencing directly from clinical specimens","volume":"215","author":"Hage","year":"2017","journal-title":"J. Infect. Dis."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653223001798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653223001798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:17:48Z","timestamp":1761362268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653223001798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":95,"alternative-id":["S1386653223001798"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2023.105556","relation":{},"ISSN":["1386-6532"],"issn-type":[{"type":"print","value":"1386-6532"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of the ViroKey\u00ae SQ FLEX assay for detection of cytomegalovirus antiviral resistance","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2023.105556","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105556"}}